Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-06-27 Purchase | 2022-06-28 6:17 pm | Nautilus Biotechnology Inc. | NAUT | Mowry Anna CFO | 5,500 | $2.7499 | $15,124 | 39,250 (Direct) | View |
2022-05-09 Purchase | 2022-05-10 8:28 pm | Nautilus Biotechnology Inc. | NAUT | Patel Sujal M CEO 10% Owner | 50,000 | $3.96 | $198,000 | 17,058,999 (Indirect Direct) | View |
2022-03-03 Purchase | 2022-03-04 5:39 pm | Nautilus Biotechnology Inc. | NAUT | Patel Sujal M CEO 10% Owner | 50,000 | $3.5978 | $179,890 | 17,797,732 (Indirect Direct) | View |
2021-12-08 Purchase | 2021-12-10 4:05 pm | Nautilus Biotechnology Inc. | NAUT | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director | 200,000 | $5.36 | $1,072,000 | 9,111,151 (Indirect) | View |
2021-11-30 Purchase | 2021-12-02 08:49 am | Nautilus Biotechnology Inc. | NAUT | Patel Sujal M CEO 10% Owner | 250,000 | $4.7247 | $1,181,176 | 16,958,899 (Indirect Direct) | View |
2021-11-30 Purchase | 2021-12-01 9:41 pm | Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director | 50,000 | $4.5101 | $225,505 | 150,000 (Indirect Direct) | View |
2021-11-24 Purchase | 2021-11-24 5:12 pm | Nautilus Biotechnology Inc. | NAUT | Mowry Anna CFO | 15,000 | $4.5755 | $68,633 | 32,500 (Direct) | View |
2021-11-15 Purchase | 2021-11-17 8:19 pm | Nautilus Biotechnology Inc. | NAUT | McIlwain Matthew S Director | 100,000 | $5.2989 | $529,890 | 6,479,845 (Indirect Direct) | View |
2021-08-24 Purchase | 2021-08-26 7:29 pm | Nautilus Biotechnology Inc. | NAUT | McIlwain Matthew S Director | 36,970 | $7.7101 | $285,041 | 6,379,845 (Indirect Direct) | View |
2021-08-12 Purchase | 2021-08-16 5:12 pm | Nautilus Biotechnology Inc. | NAUT | Mowry Anna CFO | 17,500 | $7.71 | $134,925 | 17,500 (Direct) | View |
2021-08-13 Purchase | 2021-08-13 9:01 pm | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 5,000 | $7.5613 | $37,807 | 34,140 (Indirect) | View |
2021-05-24 Purchase | 2021-06-11 5:45 pm | Nautilus Biotechnology Inc. | NAUT | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Former Director | 5,507,063 | $10 | $55,070,983 | 12,322,302 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-07-01 Ownership | 2022-07-01 5:30 pm | N/A 2030-01-30 | Nautilus Biotechnology Inc. | NAUT | Godwin Mary E. VP | 0 | $0 | 595,368 (Direct) | View |
2022-06-15 Option Award | 2022-06-17 5:43 pm | N/A 2032-06-15 | Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director | 86,467 | $0 | 86,467 (Direct) | View |
2022-06-15 Option Award | 2022-06-17 5:43 pm | N/A 2032-06-15 | Nautilus Biotechnology Inc. | NAUT | PERCEPTIVE ADVISORS LLC EDELMAN JOSEPH Director 10% Owner | 86,467 | $0 | 86,467 (Indirect) | View |
2022-06-15 Option Award | 2022-06-16 8:05 pm | N/A 2032-06-15 | Nautilus Biotechnology Inc. | NAUT | NAZEM FARZAD Director | 86,467 | $0 | 86,467 (Direct) | View |
2022-06-15 Option Award | 2022-06-16 8:04 pm | N/A 2032-06-15 | Nautilus Biotechnology Inc. | NAUT | McIlwain Matthew S Director | 86,467 | $0 | 86,467 (Direct) | View |
2022-06-15 Option Award | 2022-06-16 8:04 pm | N/A 2032-06-15 | Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director | 86,467 | $0 | 86,467 (Direct) | View |
2022-06-15 Option Award | 2022-06-16 8:03 pm | N/A 2032-06-15 | Nautilus Biotechnology Inc. | NAUT | Epperly Melissa B Director | 86,467 | $0 | 86,467 (Direct) | View |
2022-06-15 Option Award | 2022-06-16 8:03 pm | N/A 2032-06-15 | Nautilus Biotechnology Inc. | NAUT | Akinsanya Karen Director | 14,411 | $0 | 14,411 (Direct) | View |
2022-06-15 Option Award | 2022-06-16 8:03 pm | N/A 2032-06-15 | Nautilus Biotechnology Inc. | NAUT | Pande Vijay Satyanand Director | 86,467 | $0 | 86,467 (Direct) | View |
2022-05-12 Option Award | 2022-05-13 5:09 pm | N/A N/A | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 10,000 | $3.28 | 44,140 (Indirect) | View |
2022-05-04 Option Award | 2022-05-05 5:05 pm | N/A 2032-05-04 | Nautilus Biotechnology Inc. | NAUT | Nelson Nicholas A. VP | 54,422 | $0 | 54,422 (Direct) | View |
2022-05-04 Option Award | 2022-05-05 5:04 pm | N/A 2032-05-04 | Nautilus Biotechnology Inc. | NAUT | Weld Gwen E Chief People Officer | 375,000 | $0 | 375,000 (Direct) | View |
2022-04-11(A) Ownership | 2022-04-15 5:07 pm | N/A 2030-10-15 | Nautilus Biotechnology Inc. | NAUT | Weld Gwen E Chief People Officer | 0 | $0 | 4,535 (Direct) | View |
2022-03-30 Option Award | 2022-03-31 6:16 pm | N/A 2032-03-30 | Nautilus Biotechnology Inc. | NAUT | Akinsanya Karen Director | 105,998 | $0 | 105,998 (Direct) | View |
2022-03-03 Exercise | 2022-03-04 5:39 pm | N/A 2031-01-31 | Nautilus Biotechnology Inc. | NAUT | Patel Sujal M CEO 10% Owner | 100 | $0 | 17,797,732 (Direct) | View |
2022-03-03 Exercise | 2022-03-04 5:39 pm | N/A N/A | Nautilus Biotechnology Inc. | NAUT | Patel Sujal M CEO 10% Owner | 100 | $10 | 17,797,732 (Direct) | View |
2022-02-25 Option Award | 2022-02-25 8:10 pm | N/A 2032-02-25 | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 140,000 | $0 | 140,000 (Direct) | View |
2022-02-25 Option Award | 2022-02-25 8:09 pm | N/A 2032-02-25 | Nautilus Biotechnology Inc. | NAUT | Patel Sujal M CEO 10% Owner | 400,000 | $0 | 400,000 (Direct) | View |
2022-02-25 Option Award | 2022-02-25 8:09 pm | N/A 2032-02-25 | Nautilus Biotechnology Inc. | NAUT | Mallick Parag Chief Scientist 10% Owner | 280,000 | $0 | 280,000 (Direct) | View |
2022-02-25 Option Award | 2022-02-25 8:08 pm | N/A 2032-02-25 | Nautilus Biotechnology Inc. | NAUT | Sankar Subramanian VP | 140,000 | $0 | 140,000 (Direct) | View |
2022-02-25 Option Award | 2022-02-25 8:08 pm | N/A 2032-02-25 | Nautilus Biotechnology Inc. | NAUT | Nelson Nicholas A. VP | 140,000 | $0 | 140,000 (Direct) | View |
2022-02-25 Option Award | 2022-02-25 8:08 pm | N/A 2032-02-25 | Nautilus Biotechnology Inc. | NAUT | Mowry Anna CFO | 280,000 | $0 | 280,000 (Direct) | View |
2021-12-21 Gift | 2021-12-21 5:40 pm | N/A N/A | Nautilus Biotechnology Inc. | NAUT | Mallick Parag Chief Scientist 10% Owner | 210,000 | $0 | 20,479,892 (Direct) | View |
2021-06-14 Option Award | 2021-08-04 8:01 pm | N/A 2031-06-14 | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 326,526 | $0 | 326,526 (Direct) | View |
2021-05-24 Other | 2021-06-11 5:45 pm | N/A N/A | Nautilus Biotechnology Inc. | NAUT | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Former Director | 2,914,113 | $0 | 12,322,302 (Indirect) | View |
2021-06-09 Conversion | 2021-06-11 5:32 pm | N/A N/A | Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director | 4,146,500 | $0 | 543,435 (Indirect) | View |
2021-06-09 Option Award | 2021-06-11 5:32 pm | 2021-06-09 2031-06-09 | Nautilus Biotechnology Inc. | NAUT | ALTMAN MICHAEL SETH Director | 44,435 | $0 | 543,435 (Direct) | View |
2021-06-09 Ownership | 2021-06-09 9:42 pm | N/A N/A | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 0 | $0 | 29,140 (Indirect) | View |
2021-06-09 Ownership | 2021-06-09 9:41 pm | N/A 2031-01-31 | Nautilus Biotechnology Inc. | NAUT | Epperly Melissa B Director | 0 | $0 | 72,561 (Direct) | View |
2021-06-09 Ownership | 2021-06-09 9:41 pm | N/A N/A | Nautilus Biotechnology Inc. | NAUT | Mallick Parag Chief Scientist 10% Owner | 0 | $0 | 21,153,911 (Direct) | View |